Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 603 51 713.7 |
96 | EP file number | EAKZ | 10 00 5016.0 |
97 | EP publication number | EPN | 2228390 |
54 | Designation/title | TI | Therapeutische Verwendungen von monoklonalen Antikörpern gegen den Angiotensin-II Typ-1 Rezeptor |
51 | IPC main class | ICM (ICMV) | C07K 14/72 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07K 16/28 (2006.01), A61K 38/17 (2006.01), A61K 39/395 (2006.01), A61K 47/64 (2017.01), A61K 39/00 (2006.01) |
22 | DE application date | DAT | Aug 21, 2003 |
96 | EP application date | EAT | Aug 21, 2003 |
43 | Date of first publication | OT | Sep 15, 2010 |
| Date of publication of grant | PET | Dec 19, 2018 |
71/73 | Applicant/owner | INH | Queen Mary and Westfield College, London, GB |
72 | Inventor | IN | Vinson, Gavin Paul, London E1 4NS, GB; Puddefoot, John Richard, London E1 4NS, GB; Barker, Stewart, London E1 4NS, GB |
| Address for service | | Kilburn & Strode LLP, London WC1X 8NL, GB |
33 31 32
| Foreign priority | PRC PRNA PRDA
| GB 0219524 Aug 21, 2002
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002228390 Searchable text:
EP000002228390 Original document:
EP000002228390B1 Searchable text:
EP000002228390B1 |
43 | Date of first publication | EVT | Sep 15, 2010 |
| Date of the first transfer into DPMAregister | EREGT | May 26, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | May 25, 2022 (Show all update days)(Hide all update days)- May 26, 2011
- Date of the first transfer into DPMAregister
|